amira el tokhy

Dr. amira el tokhy

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2023 in Redox Report
Verified
Journal Article
Open access
HRHanem M. Rabah
Hanem M. Rabah
DMDarin A. Mohamed
Darin A. Mohamed
RMReham A. Mariah
Reham A. Mariah
SESarah R. Abd El-Khalik
Sarah R. Abd El-Khalik
HKHaidy A. Khattab
Haidy A. Khattab
ATamira el tokhy
amira el tokhy
Polycystic ovary syndrome (PCOS) has a series of reproductive and metabolic consequences. Although the link between PCOS, IR, and obesity, their impact on the pathogenesis of PCOS has yet to be det...

12 April 2023 in Cell Biochemistry and Function
Verified
Journal Article
Closed access
YAYasser Mohamed Atef
Yasser Mohamed Atef
YHYasser Mostafa Hafez
Yasser Mostafa Hafez
OEOmnia Safwat El‐Deeb
Omnia Safwat El‐Deeb
EBEman H. Basha
Eman H. Basha
RIRadwa Ismail
Radwa Ismail
ATamira el tokhy
amira el tokhy

26 December 2024 in Redox Report
Verified
Journal Article
Open access
ATamira el tokhy
amira el tokhy
RERehab Ahmed Ahmed El-Shaer
Rehab Ahmed Ahmed El-Shaer
OEOmnia Safwat El-Deeb
Omnia Safwat El-Deeb
EFEman E. Farghal
Eman E. Farghal
RIRowida Ibrahim
Rowida Ibrahim
MAMarwa Mohamed Atef
Marwa Mohamed Atef
The most prevalent endocrine disorder affecting women is PCOS. Programmed death of ovarian cells has yet to be elucidated. Ferroptosis is a kind of iron-dependent necrosis featured by significantly Fe+2-dependent lipid peroxidation. The ongoing study aimed to reinforce fertility by combining therapy with AgNPs and (Zileuton) in PCOS rats' model. The study included 75 adult female rats divided into 5 groups; control, PCOS, PCOS treated with AgNPs, PCOS treated with Zileuton, and PCOS group treated with AgNPs and Zileuton. The study investigated the anti-ferroptotic, anti-inflammatory, antioxidant, antiapoptotic, histopathological and immunohistochemical examinations of COX-2 and VEGF. The combination of AgNPs and Zileuton showed significant reduction of inflammatory mediators (IL-6, TNF-α, NFk-B) compared with diseased group (P-value < 0.05), regression of ferroptosis marks (Panx1 and TLR4 expression, Fe+2 levels) compared with diseased group (P-value < 0.05), depression of apoptotic marker caspase 3 level compared with diseased animals (P-value < 0.05), depression of MDA level, elevation of HO-1, GPx4 activity, and reduction of Cox2 and VEGF as compared with the diseased, AgNPs or zileuton-treated groups (P-value < 0.05). The study showed that the combination of AgNPs and zileuton guards against, inflammation, apoptosis, and ferroptosis in PCO.

29 October 2021 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
ATamira el tokhy
amira el tokhy
OTOsama Toema
Osama Toema
OEOmnia Safwat El-Deeb
Omnia Safwat El-Deeb

18 June 2021 in Journal of Diabetes & Metabolic Disorders
Verified
Journal Article
Closed access
PDF file
ATamira el tokhy
amira el tokhy
HKHaidy Abdelaziz Khattab
Haidy Abdelaziz Khattab
HRHanem Mohamed Rabah
Hanem Mohamed Rabah

1 January 2026 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
RERehab Ahmed Ahmed El-Shaer
Rehab Ahmed Ahmed El-Shaer
SISarah Ibrahim
Sarah Ibrahim
NANorhan Ahmed AbuoHashish
Norhan Ahmed AbuoHashish
ATamira el tokhy
amira el tokhy
HGHeba Bassiony Ghanem
Heba Bassiony Ghanem
MAMarwa Mahmoud Awad
Marwa Mahmoud Awad
Background: Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are severe inflammatory lung disorders associated with high morbidity and mortality. Dysregulation of the renin–angiotensin system (RAS) and proinflammatory pathways play an indispensable role in ALI progression. Aim: This study aimed to investigate the protective potential of nobiletin (NOB) in mitigating ALI and hyperinflammatory lung injury. Material and Methods: The study enrolled 32 male albino rats allocated into four groups: (Control, NOB, lipopolysaccharide [LPS], and NOB + LPS groups). Rats received NOB 20 mg/kg by oral gavage for 1 week; on the seventh day, a single dose of 15 mg/kg LPS was given by intranasal instillation. After 24 h of LPS administration, plasma and lung tissue samples were analyzed for inflammatory cytokines, mitochondrial complex‐I, oxidative stress markers, and molecular signaling pathways. Results: NOB administration significantly downregulated miR‐200 expression, associated with ACE2 activation and attenuated AT1R‐mediated inflammatory responses. It also decreased NF‐κB and p38 MAPK signaling, reducing pulmonary and systemic levels of tumor necrosis factor‐alpha (TNF‐α), interleukin‐6 (IL‐6), granulocyte monocyte‐colony stimulating factor (GM‐CSF), and interleukin‐17A (IL‐17A). Additionally, NOB improved the high mobility group box 1 (HMGB1)/NF‐κB/mammalian target of rapamycin (mTOR) pathway, and increased mitochondrial complex‐I may be consistent with improved tissue preservation. Conclusion: NOB exerts protective effects against ALI by improving inflammatory cytokine, oxidative stress, miRNA‐200, mitochondrial complex‐I, and ACE2, highlighting its potential as a protective candidate for ALI and hyperinflammatory‐associated lung injury.